Matches in Nanopublications for { ?s ?p "[The CXCR4 promoter is shown to have a 'tumor-on' and 'liver-off' status in vitro and in vivo, and CXCR4 may prove to be a good candidate TSP for cancer gene therapy approaches for melanoma and breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP265942.RA3xFoEfv54sKIswCFBx2p2lRILG3yk3QZQ45ihokhzus130_assertion description "[The CXCR4 promoter is shown to have a 'tumor-on' and 'liver-off' status in vitro and in vivo, and CXCR4 may prove to be a good candidate TSP for cancer gene therapy approaches for melanoma and breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265942.RA3xFoEfv54sKIswCFBx2p2lRILG3yk3QZQ45ihokhzus130_provenance.
- NP430625.RA3dyxaC7x9cl9n6kdEyjVNQehqDlddMPTQSy4w5hTiTo130_assertion description "[The CXCR4 promoter is shown to have a 'tumor-on' and 'liver-off' status in vitro and in vivo, and CXCR4 may prove to be a good candidate TSP for cancer gene therapy approaches for melanoma and breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430625.RA3dyxaC7x9cl9n6kdEyjVNQehqDlddMPTQSy4w5hTiTo130_provenance.
- NP499497.RAMCrlqR553EBEjNFlexmv1Wf28D2L764XKBkNsLJxjYI130_assertion description "[The CXCR4 promoter is shown to have a 'tumor-on' and 'liver-off' status in vitro and in vivo, and CXCR4 may prove to be a good candidate TSP for cancer gene therapy approaches for melanoma and breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499497.RAMCrlqR553EBEjNFlexmv1Wf28D2L764XKBkNsLJxjYI130_provenance.
- assertion description "[The CXCR4 promoter is shown to have a 'tumor-on' and 'liver-off' status in vitro and in vivo, and CXCR4 may prove to be a good candidate TSP for cancer gene therapy approaches for melanoma and breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The CXCR4 promoter is shown to have a 'tumor-on' and 'liver-off' status in vitro and in vivo, and CXCR4 may prove to be a good candidate TSP for cancer gene therapy approaches for melanoma and breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP436247.RAQQeOBD-8AXQbQTT_qc7rd9KHAG_ga0MH14thCIpAP1Q130_assertion description "[The CXCR4 promoter is shown to have a 'tumor-on' and 'liver-off' status in vitro and in vivo, and CXCR4 may prove to be a good candidate TSP for cancer gene therapy approaches for melanoma and breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP436247.RAQQeOBD-8AXQbQTT_qc7rd9KHAG_ga0MH14thCIpAP1Q130_provenance.
- NP436248.RAXgtMJNcbgEIOEF4mWycyV4uIrEK-UJ77h9-mhuUMzVQ130_assertion description "[The CXCR4 promoter is shown to have a 'tumor-on' and 'liver-off' status in vitro and in vivo, and CXCR4 may prove to be a good candidate TSP for cancer gene therapy approaches for melanoma and breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP436248.RAXgtMJNcbgEIOEF4mWycyV4uIrEK-UJ77h9-mhuUMzVQ130_provenance.